Ganglioneuroblastoma in children

[1]  Shogo Kobayashi,et al.  Usefulness of fluorodeoxyglucose positron emission tomography/computed tomography for detection of a neuroblastic nodule in a ganglioneuroblastoma: a case report , 2018, Journal of Medical Case Reports.

[2]  Arnab Ghosh,et al.  Ganglioneuroblastoma in a newborn with multiple metastases: a case report , 2017, Journal of Medical Case Reports.

[3]  Yongbo Huang,et al.  Surgical management and outcomes of ganglioneuroma and ganglioneuroblastoma-intermixed , 2017, Pediatric Surgery International.

[4]  Gang Ren,et al.  Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma , 2017, Oncotarget.

[5]  F. Berthold,et al.  Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed , 2016, BMC Cancer.

[6]  J. Sandoval,et al.  Hepatic metastatic disease in pediatric and adolescent solid tumors. , 2015, World journal of hepatology.

[7]  R. Hewitt,et al.  Primary cervical ganglioneuroblastoma. , 2015, International journal of pediatric otorhinolaryngology.

[8]  Sara M. Federico,et al.  The role of chest computed tomography (CT) as a surveillance tool in children with high‐risk neuroblastoma , 2015, Pediatric blood & cancer.

[9]  A. Vicha,et al.  Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification , 2014, British Journal of Cancer.

[10]  R. Prayson,et al.  Pediatric cerebral ganglioneuroblastoma , 2014, Journal of Clinical Neuroscience.

[11]  J. Neuhaus,et al.  Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Derek Stephens,et al.  Metastatic neuroblastoma confined to distant lymph nodes (stage 4N) predicts outcome in patients with stage 4 disease: A study from the International Neuroblastoma Risk Group Database. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  B. Harding,et al.  Imaging findings of patients with metastatic neuroblastoma to the brain. , 2014, Academic radiology.

[14]  A. Naranjo,et al.  A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants: A Children's Oncology Group Study , 2012, Annals of surgery.

[15]  J. Maris,et al.  Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children's Oncology Group study P9641. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  O. Delattre,et al.  Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study) , 2011, British Journal of Cancer.

[17]  B. Hero,et al.  Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. , 2011, Radiology.

[18]  P. Kaatsch.  Epidemiology of childhood cancer. , 2010, Cancer treatment reviews.

[19]  A. Look,et al.  Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG , 2009, Pediatric blood & cancer.

[20]  H. Shimada,et al.  The International Neuroblastoma Pathology Classification. , 2003, Pathologica.

[21]  K K Matthay,et al.  The International Neuroblastoma Pathology Classification (the Shimada system) , 1999, Cancer.

[22]  U. Zaleska-Dorobisz,et al.  [Ganglioneuroblastoma in a child with chronic abdominal pain - a case report]. , 2018, Developmental period medicine.

[23]  S. Bhatia,et al.  Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.